Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer

Our aim was to evaluate the efficacy and safety of cisplatin with pemtrexed or vinorelbine and concurrent late course accelerated hyperfractionated radiotherapy (LCAHRT). Patients with unresectable stage III non-small-cell lung cancer (NSCLC) were randomly assigned to two regimens. The experimental...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qian, Wang, Zhongtang, Huang, Wei, Wang, Qiang, Yu, Shuzeng, Zhou, Tao, Han, Dan, Wu, Zhenying, Gong, Heyi, Sun, Hongfu, Zhang, Jian, Wei, Yumei, Li, Hongsheng, Zhang, Zicheng, Lin, Haiqun, Li, Baosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885003/
https://www.ncbi.nlm.nih.gov/pubmed/26761213
http://dx.doi.org/10.18632/oncotarget.6871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885003/
https://www.ncbi.nlm.nih.gov/pubmed/26761213
http://dx.doi.org/10.18632/oncotarget.6871

Ejemplares similares